Published on 23 Mar 2024 on Simply Wall St. via Yahoo Finance
Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the...
Key Insights
Significantly high institutional ownership implies Astria Therapeutics' stock price is sensitive to their trading actionsThe top 7 shareholders own 52% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
If you want to know who really controls Astria Therapeutics, Inc. (NASDAQ:ATXS), then you'll have to look at the makeup of its share registry. With 53% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).